Navigation Links
Blood test accurately distinguishes depressed patients from healthy controls
Date:2/1/2012

The initial assessment of a blood test to help diagnose major depressive disorder indicates it may become a useful clinical tool. In a paper published in the journal Molecular Psychiatry, a team including Massachusetts General Hospital (MGH) researchers reports that a test analyzing levels of nine biomarkers accurately distinguished patients diagnosed with depression from control participants without significant false-positive results.

"Traditionally, diagnosis of major depression and other mental disorders has been made based on patients' reported symptoms, but the accuracy of that process varies a great deal, often depending on the experience and resources of the clinician conducting the assessment," says George Papakostas, MD, of the MGH Department of Psychiatry, lead and corresponding author of the report. "Adding an objective biological test could improve diagnostic accuracy and may also help us track individual patients' response to treatment."

The study authors note that previous efforts to develop tests based on a single blood or urinary biomarker did not produce results of sufficient sensitivity, the ability to detect the tested-for condition, or specificity, the ability to rule out that condition. "The biology of depression suggests that a highly complex series of interactions exists between the brain and biomarkers in the peripheral circulation," says study co-author John Bilello, PhD, chief scientific officer of Ridge Diagnostics (http://www.ridgedx.com), which sponsored the current study. "Given the complexity and variability of these types of disorders and the associated biomarkers in an individual, it is easy to understand why approaches measuring a single factor would not have sufficient clinical utility."

The test developed by Ridge Diagnostics measures levels of nine biomarkers associated with factors such as inflammation, the development and maintenance of neurons, and the interaction between brain structures involved with stress response and other key functions. Those measurements are combined using a specific formula to produce a figure called the MDDScore a number from 1 to 100 indicating the percentage likelihood that the individual has major depression. In clinical use the MDDScore would range from 1 to 10.

The initial pilot phase of the study enrolled 36 adults who had been diagnosed with major depression at the MGH, Vanderbilt University or Cambridge Health Alliance in Cambridge, Mass., along with 43 control participants from St. Elizabeth's Hospital in Brighton, Mass. MDDScores for 33 of the 36 patients indicated the presence of depression, while only 8 of the 43 controls had a positive test result. The average score for patients was 85, while the average for controls was 33. A second replication phase enrolled an additional 34 patients from the MGH and Vanderbilt, 31 of whom had a positive MDDScore result. Combining both groups indicated that the test could accurately diagnose major depression with a sensitivity of about 90 percent and a specificity of 80 percent.

"It can be difficult to convince patients of the need for treatment based on the sort of questionnaire now used to rank their reported symptoms," says Bilello. "We expect that the biological basis of this test may provide patients with insight into their depression as a treatable disease rather than a source of self-doubt and stigma. As we accumulate additional data on the MDDScore and perform further studies, we hope it will be useful for predicting treatment response and helping to select the best therapies."

Papakostas adds, "Determining the true utility of this test will require following this small research study with larger trials in clinical settings. But these results are already providing us with intriguing new hints on how powerfully factors such as inflammation which we are learning has a major role in many serious medical issues contribute to depression." Papakostas is an associate professor of Psychiatry at Harvard Medical School.


'/>"/>
Contact: Kristen Stanton
kstanton3@partners.org
617-643-3907
Massachusetts General Hospital
Source:Eurekalert

Related medicine news :

1. 2-arm blood pressure check indicator for risk from heart disease or death
2. Lifestyle Counseling Helps Diabetes Patients Control Blood Sugar
3. Could Alzheimers disease be diagnosed with a simple blood test?
4. Lead blood levels may increase smokers risk for kidney cancer
5. Repeat Scans Urged for Head Injury When Blood Thinners Involved
6. Experimental Blood Thinner Given Before Surgery Shows Benefit
7. Upper Normal Blood Pressure Linked to Heart Risk in Men
8. Joint Replacement Patients Face Blood Clot Risk in Hospital
9. Canadas first renal denervation procedure to reduce high blood pressure performed today
10. New Blood Thinner Linked to Higher Heart Attack Risk
11. Short Delay in Treating Blood Pressure Safe for Diabetics: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... ... February 28, 2017 , ... In 2014, Harvard researchers ... studying approximately 800 deaths from prostate cancer, the researchers found that men who had ... likely to get fatal prostate cancer. Although the increased risks are small, they seem ...
(Date:2/28/2017)... ... , ... February is American Heart Month sponsored by The American Heart Association. ... cardiovascular health for themselves, their families and their communities. , Heart disease is ... deaths are caused by heart disease. Nearly half of all Americans have at least ...
(Date:2/28/2017)... ... ... BrightStar Care Marietta announced that it has received the 2017 Best of Home ... only to top-ranking home care providers, based on client satisfaction scores gathered by Home ... from across the country who have proven their ability to provide the highest quality ...
(Date:2/28/2017)... ... February 28, 2017 , ... ... from 4:30-5:30 p.m. at the 11th Annual RISE Nashville Summit. RISE Nashville is ... performance analytics, and engagement strategies. , The discussion will include best practices for ...
(Date:2/27/2017)... CA (PRWEB) , ... February 27, 2017 , ... ... muscle mass and overall body strength, which often leads to a host of ... Journal of the American Geriatrics Society discovered that good overall muscle ...
Breaking Medicine News(10 mins):
(Date:2/28/2017)... This report provides all the information you ... and activities since 2010. Download the full ... Deals and Alliance since 2010 report provides an in-depth ... world,s leading life sciences companies. On demand ... of the most up to date deal and company ...
(Date:2/28/2017)... 2017   Fourth-quarter 2016 ... $4,010 million to top end of guidance ... impairment charges in fourth-quarter 2016 associated with the write-down ... Company,s Generics reporting unit ... continuing operations; Full-year 2016 reported $14.48 diluted (GAAP) loss ...
(Date:2/27/2017)... Inc. (NYSE: HYH ) today reported fourth quarter ... related key planning assumptions. Executive Summary 2016 fourth ... compared to the prior year. Net income ... net income of $15 million in the fourth quarter of ... to adjusted net income of $27 million in the prior ...
Breaking Medicine Technology: